Skip to content Skip to footer

SMURF-Therapeutics

Close

news archives

news archives

SMURF-Therapeutics

NEWS ARCHIVES

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease | NEJM

Nov252021
Time: 12:00 am - 12:00 am
Read More

Smurf2 Regulation of HIF-1α in Cancer Cells

Sep292021
Time: 12:00 am - 12:00 am
Watch Now

Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase | Oncotarget

Sep282021
Time: 12:00 am - 12:00 am
Read More

FDA approves belzutifan for cancers associated with von Hippel-Lindau disease | FDA

Aug132021
Time: 12:00 am - 12:00 am
Read More

Dr. Wafik El-Deiry comments on the future of cancer treatment

Feb262020
Time: 12:00 am - 12:00 am

Watch Now
Go to Top